ÂÜÀòÂÒÂ×

Dr. Yongxin Han is the Executive Vice President and Head of Drug Discovery at Nested Therapeutics. In his career as a drug hunter, Yongxin led multiple teams in their discovery and advancement of twelve development candidates in oncology, immune-oncology, chronic HIV and HCV infections, pain and inflammation, metabolic disorders, hypertension, and glaucoma (PCCs). He also co-led and was a core member of several Early Development Teams that managed development activities up to clinical proof-of-concept. Before joining Nested Therapeutics, Yongxin spent more than 27 years at Merck Research Laboratories (MRL) in Montreal Canada, Shanghai China, and Boston USA. In his distinguished career at MRL, he served as a respected mentor, authored and co-authored over fifty-five publications in peer reviewed journals, and invented and co-invented more than seventy patents. Yongxin earned his Ph.D. in Organic Chemistry from the University of Alberta and completed his postdoctoral training from the University of British Columbia.